{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:58:21Z","timestamp":1778641101619,"version":"3.51.4"},"reference-count":51,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1248\/bpb.b20-00432","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T22:06:18Z","timestamp":1598911578000},"page":"1413-1420","source":"Crossref","is-referenced-by-count":13,"title":["A Lipid-Based Nanocarrier Containing Active Vitamin D<sub>3<\/sub> Ameliorates NASH in Mice <i>via<\/i> Direct and Intestine-Mediated Effects on Liver Inflammation"],"prefix":"10.1248","volume":"43","author":[{"given":"Yunmei","family":"Mu","sequence":"first","affiliation":[{"name":"Graduate School of Systems Life Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinting","family":"Li","sequence":"additional","affiliation":[{"name":"Graduate School of Systems Life Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Hun","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Biopharmaceutics and Pharmacokinetics, National Cerebral and Cardiovascular Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinako","family":"Eto","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical Initiatives, Faculty of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadijah","family":"Zai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science and Technology, Universitas Gadjah Mada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Kishimura","sequence":"additional","affiliation":[{"name":"Graduate School of Systems Life Sciences, Kyushu University"},{"name":"Department of Applied Chemistry, Faculty of Engineering, Kyushu University"},{"name":"Center for Future Chemistry, Kyushu University"},{"name":"International Research Center for Molecular System, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Hyodo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Frontier Science for Imaging, Gifu University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Mori","sequence":"additional","affiliation":[{"name":"Graduate School of Systems Life Sciences, Kyushu University"},{"name":"Department of Applied Chemistry, Faculty of Engineering, Kyushu University"},{"name":"Center for Future Chemistry, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Katayama","sequence":"additional","affiliation":[{"name":"Graduate School of Systems Life Sciences, Kyushu University"},{"name":"Department of Applied Chemistry, Faculty of Engineering, Kyushu University"},{"name":"Center for Future Chemistry, Kyushu University"},{"name":"International Research Center for Molecular System, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Brunt EM. Nonalcoholic steatohepatitis. Semin. Liver Dis.<\/i>, 24<\/b>, 3\u201320 (2004).","DOI":"10.1055\/s-2004-823098"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med.<\/i>, 24<\/b>, 908\u2013922 (2018).","DOI":"10.1038\/s41591-018-0104-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology<\/i>, 64<\/b>, 73\u201384 (2016).","DOI":"10.1002\/hep.28431"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut\u2013liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol.<\/i>, 15<\/b>, 397\u2013411 (2018).","DOI":"10.1038\/s41575-018-0011-z"},{"key":"5","unstructured":"5) Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, Keshavarzian A. Susceptibility to gut leakiness: A possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int.<\/i>, 28<\/b>, 1026\u20131033 (2008)."},{"key":"6","unstructured":"6) Lonardo A, Nascimbeni F, Targher G, Bernardi M, Bonino F, Bugianesi E, Casini A, Gastaldelli A, Marchesini G, Marra F, Miele L, Morisco F, Petta S, Piscaglia F, Svegliati-Baroni G, Valenti L, Bellentani S. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Dig. Liver Dis.<\/i>, 49<\/b>, 471\u2013483 (2017)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E. The role of the microbiome in NAFLD and NASH. EMBO Mol. Med.<\/i>, 11<\/b>, 1\u201313 (2019).","DOI":"10.15252\/emmm.201809302"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Diehl AM, Li ZP, Lin HZ, Yang SQ. Cytokines and the pathogenesis of non-alcoholic steatohepatitis. Gut<\/i>, 54<\/b>, 303\u2013306 (2005).","DOI":"10.1136\/gut.2003.024935"},{"key":"9","unstructured":"9) Albillos A, De Gottardi A, Rescigno M. The gut\u2013liver axis in liver disease: pathophysiological basis for therapy. J. Hepatol.<\/i>, 72<\/b>, 558\u2013577 (2020)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med.<\/i>, 9<\/b>, 85 (2011).","DOI":"10.1186\/1741-7015-9-85"},{"key":"11","unstructured":"11) Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, Koteish AA, Clark JM, Guallar E, Hernaez R. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther.<\/i>, 38<\/b>, 246\u2013254 (2013)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell<\/i>, 126<\/b>, 789\u2013799 (2006).","DOI":"10.1016\/j.cell.2006.06.049"},{"key":"13","unstructured":"13) Eliades M, Spyrou E. Vitamin D: a new player in non-alcoholic fatty liver disease? World J. Gastroenterol.<\/i>, 21<\/b>, 1718\u20131727 (2015)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response. Cell<\/i>, 153<\/b>, 601\u2013613 (2013).","DOI":"10.1016\/j.cell.2013.03.028"},{"key":"15","unstructured":"15) Clark A, Mach N. Role of vitamin D in the hygiene hypothesis: The interplay between vitamin D, vitamin D receptors, gut microbiota, and immune response. Front. Immunol.<\/i>, 7<\/b>, 627 (2016)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Su D, Nie Y, Zhu A, Chen Z, Wu P, Zhang L, Luo M, Sun Q, Cai L, Lai Y, Xiao Z, Duan Z, Zheng S, Wu G, Hu R, Tsukamoto H, Lugea A, Liu Z, Pandol SJ, Han YP. Vitamin D signaling through induction of paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal models. Front. Physiol.<\/i>, 7<\/b>, 498 (2016).","DOI":"10.3389\/fphys.2016.00498"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sharifi N, Amani R, Hajiani E, Cheraghian B. Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers. Exp. Biol. Med.<\/i>, 241<\/b>, 830\u2013838 (2016).","DOI":"10.1177\/1535370216629009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sharifi N, Amani R, Hajiani E, Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine<\/i>, 47<\/b>, 70\u201380 (2014).","DOI":"10.1007\/s12020-014-0336-5"},{"key":"19","unstructured":"19) Tebben PJ, Singh RJ, Kumar R. Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr. Rev.<\/i>, 37<\/b>, 521\u2013547 (2016)."},{"key":"20","unstructured":"20) Lorvand Amiri H, Agah S, Tolouei Azar J, Hosseini S, Shidfar F, Mousavi SN. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: randomized, controlled, double-blind trial. Clin. Nutr.<\/i>, 36<\/b>, 1490\u20131497 (2017)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zai K, Hirota M, Yamada T, Ishihara N, Mori T, Kishimura A, Suzuki K, Hase K, Katayama Y. Therapeutic effect of vitamin D3-containing nanostructured lipid carriers on inflammatory bowel disease. J. Control. Release<\/i>, 286<\/b>, 94\u2013102 (2018).","DOI":"10.1016\/j.jconrel.2018.07.019"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Beloqui A, Solin\u00eds M\u00c1, Gasc\u00f3n AR, Del Pozo-Rodr\u00edguez A, Des Rieux A, Pr\u00e9at V. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J. Control. Release<\/i>, 166<\/b>, 115\u2013123 (2013).","DOI":"10.1016\/j.jconrel.2012.12.021"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Luther J, Garber JJ, Khalili H, Dave M, Bale SS, Jindal R, Motola DL, Luther S, Bohr S, Jeoung SW, Deshpande V, Singh G, Turner JR, Yarmush ML, Chung RT, Patel SJ. Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability. Cmgh<\/i>, 1<\/b>, 222\u2013232.e2 (2015).","DOI":"10.1016\/j.jcmgh.2015.01.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology<\/i>, 41<\/b>, 1313\u20131321 (2005).","DOI":"10.1002\/hep.20701"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro<\/i> and in vivo<\/i> by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol.<\/i>, 182<\/b>, 375\u2013387 (2013).","DOI":"10.1016\/j.ajpath.2012.10.014"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY. Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J. Immunol.<\/i>, 195<\/b>, 4999\u20135010 (2015).","DOI":"10.4049\/jimmunol.1402598"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nighot M, Al-Sadi R, Guo S, Rawat M, Nighot P, Watterson MD, Ma TY. Lipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by toll-like receptor 4\/Myeloid Differentiation Primary Response 88 (MyD88) activation of myosin light chain kinase expression. Am. J. Pathol.<\/i>, 187<\/b>, 2698\u20132710 (2017).","DOI":"10.1016\/j.ajpath.2017.08.005"},{"key":"28","unstructured":"28) Clark A, Mach N. Role of vitamin D in the hygiene hypothesis: The interplay between vitamin D, vitamin D receptors, gut microbiota, and immune response. Front. Immunol.<\/i>, 7<\/b>, 627 (2016)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Chen G, Ran X, Li B, Li Y, He D, Huang B, Fu S, Liu J, Wang W. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine<\/i>, 30<\/b>, 317\u2013325 (2018).","DOI":"10.1016\/j.ebiom.2018.03.030"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Tanoue T, Nishitani Y, Kanazawa K, Hashimoto T, Mizuno M. In vitro<\/i> model to estimate gut inflammation using co-cultured Caco-2 and RAW264.7 cells. Biochem. Biophys. Res. Commun.<\/i>, 374<\/b>, 565\u2013569 (2008).","DOI":"10.1016\/j.bbrc.2008.07.063"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am. J. Physiol. Gastrointest. Liver Physiol.<\/i>, 287<\/b>, G264\u2013G273 (2004).","DOI":"10.1152\/ajpgi.00002.2004"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ye J, Lv L, Wu W, Li Y, Shi D, Fang D, Guo F, Jiang H, Yan R, Ye W, Li L. Butyrate protects mice against methionine\u2013choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels. Front. Microbiol.<\/i>, 9<\/b>, 1967 (2018).","DOI":"10.3389\/fmicb.2018.01967"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch. Biochem. Biophys.<\/i>, 417<\/b>, 77\u201380 (2003).","DOI":"10.1016\/S0003-9861(03)00338-2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Swami S, Krishnan AV, Wang JY, Jensen K, Horst R, Albertelli MA, Feldman D. Dietary vitamin D 3and 1,25-dihydroxyvitamin D 3 (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology<\/i>, 153<\/b>, 2576\u20132587 (2012).","DOI":"10.1210\/en.2011-1600"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Rizki G, Arnaboldi L, Gabrielli B, Yan J, Lee GS, Ng RK, Turner SM, Badger TM, Pitas RE, Maher JJ. Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J. Lipid Res.<\/i>, 47<\/b>, 2280\u20132290 (2006).","DOI":"10.1194\/jlr.M600198-JLR200"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Patel DP, Yan T, Kim D, Dias HB, Krausz KW, Kimura S, Gonzalez FJ. Withaferin A improves nonalcoholic steatohepatitis in mice. J. Pharmacol. Exp. Ther.<\/i>, 371<\/b>, 360\u2013374 (2019).","DOI":"10.1124\/jpet.119.256792"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Li R, Li J, Huang Y, Li H, Yan S, Lin J, Chen Y, Wu L, Liu B, Wang G, Lan T. Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice. Int. J. Biol. Sci.<\/i>, 14<\/b>, 1411\u20131425 (2018).","DOI":"10.7150\/ijbs.26086"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Armstrong JK, Wenby RB, Meiselman HJ, Fisher TC. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys. J.<\/i>, 87<\/b>, 4259\u20134270 (2004).","DOI":"10.1529\/biophysj.104.047746"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1\u03b2-induced increase in intestinal epithelial tight junction permeability. J. Immunol.<\/i>, 180<\/b>, 5653\u20135661 (2008).","DOI":"10.4049\/jimmunol.180.8.5653"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Al-Sadi R, Ye D, Boivin M, Guo S, Hashimi M, Ereifej L, Ma TY. Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway. PLOS ONE<\/i>, 9<\/b>, e85345 (2014).","DOI":"10.1371\/journal.pone.0085345"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb. Perspect. Biol.<\/i>, 2<\/b>, a002907 (2010).","DOI":"10.1101\/cshperspect.a002907"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Kazankov K, J\u00f8rgensen SMD, Thomsen KL, M\u00f8ller HJ, Vilstrup H, George J, Schuppan D, Gr\u00f8nb\u00e6k H. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat. Rev. Gastroenterol. Hepatol.<\/i>, 16<\/b>, 145\u2013159 (2019).","DOI":"10.1038\/s41575-018-0082-x"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Takahashi Y, Fukusato T. Animal models of liver diseases. Animal models for the study of human disease<\/i>. (Second ed.) Elsevier Inc., the Netherlands (2017).","DOI":"10.1016\/B978-0-12-809468-6.00013-9"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Su YB, Li TH, Huang CC, Tsai HC, Huang SF, Hsieh YC, Yang YY, Huang YH, Hou MC, Lin HC. Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal\/adipose tissue alteration in a diet-induced steatohepatitis rat model. PLOS ONE<\/i>, 13<\/b>, e0194867 (2018).","DOI":"10.1371\/journal.pone.0194867"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Yin Y, Yu Z, Xia M, Luo X, Lu X, Ling W. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. Eur. J. Clin. Invest.<\/i>, 42<\/b>, 1189\u20131196 (2012).","DOI":"10.1111\/j.1365-2362.2012.02706.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Liu XJ, Wang BW, Zhang C, Xia MZ, Chen YH, Hu CQ, Wang H, Chen X, Xu DX. Vitamin D deficiency attenuates high-fat diet-induced hyperinsulinemia and hepatic lipid accumulation in male mice. Endocrinology<\/i>, 156<\/b>, 2103\u20132113 (2015).","DOI":"10.1210\/en.2014-2037"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Zhang H, Shen Z, Lin Y, Zhang J, Zhang Y, Liu P, Zeng H, Yu M, Chen X, Ning L, Mao X, Cen L, Yu C, Xu C, Tang QQ. Vitamin D receptor targets hepatocyte nuclear factor 4\u03b1 and mediates protective effects of Vitamin D in nonalcoholic fatty liver disease. J. Biol. Chem.<\/i>, 295<\/b>, 3891\u20133905 (2020).","DOI":"10.1074\/jbc.RA119.011487"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Jahn D, Dorbath D, Kircher S, Nier A, Bergheim I, Lenaerts K, Hermanns HM, Geier A. Beneficial effects of vitamin D treatment in an obese mouse model of non-alcoholic steatohepatitis. Nutrients.<\/i>, 11<\/b>, 77 (2019).","DOI":"10.3390\/nu11010077"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Marziou A, Philouze C, Couturier C, Astier J, Obert P, Landrier JF, Riva C. Vitamin D supplementation improves adipose tissue inflammation and reduces hepatic steatosis in obese C57BL\/6J mice. Nutrients<\/i>, 12<\/b>, 342 (2020).","DOI":"10.3390\/nu12020342"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Yu Q, Hu X, Ma Y, Xie Y, Lu Y, Qi J, Xiang L, Li F, Wu W. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus. Drug Deliv.<\/i>, 23<\/b>, 1469\u20131475 (2016).","DOI":"10.3109\/10717544.2016.1153744"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall H-U, Kipnes M, Adorini L, Sciacca CI, Clopton P, Castelloe E, Dillon P, Pruzanski M, Shapiro D. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology<\/i>, 145<\/b>, 574\u2013582.e1 (2013).","DOI":"10.1053\/j.gastro.2013.05.042"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/9\/43_b20-00432\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T03:23:43Z","timestamp":1599276223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/9\/43_b20-00432\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00432","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}